Key result
White-coat hypertension was investigated for its associated cardiovascular risk, but the provided abstract contains only funding information and no clinical findings.
Key points are not available for this paper at this time.
Does not alter white-coat hypertension management; leaves open its cardiovascular risk pending complete data.
sponsorship: The European Union (HEALTH-F7-305507 HOMAGE) and the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uP-ROPHET) currently support research at the Studies Coordinating Centre in Leuven. (European Union|HEALTH-F7-305507 HOMAGE, European Research Council|2011-294713-EPLORE, European Research Council|713601-uP-ROPHET)
No takes yet. Share an insight, caveat, or question.
Asayama et al. (2017) studied this question. White-coat hypertension was investigated for its associated cardiovascular risk, but the provided abstract contains only funding information and no clinical findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: